Accelerate Diagnostics Price Prediction

AXDXDelisted Stock  USD 0.04  0.02  164.90%   
At this time, the value of RSI of Accelerate Diagnostics' share price is approaching 32. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Accelerate Diagnostics, making its price go up or down.

Momentum 32

 Sell Stretched

 
Oversold
 
Overbought
The successful prediction of Accelerate Diagnostics' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Accelerate Diagnostics, which may create opportunities for some arbitrage if properly timed.
Using Accelerate Diagnostics hype-based prediction, you can estimate the value of Accelerate Diagnostics from the perspective of Accelerate Diagnostics response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Accelerate Diagnostics to buy its stock at a price that has no basis in reality. In that case, they are not buying Accelerate because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Accelerate Diagnostics after-hype prediction price

    
  USD 0.0361  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Accelerate Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.000.0423.04
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.00820.070.14
Details

Accelerate Diagnostics After-Hype Price Prediction Density Analysis

As far as predicting the price of Accelerate Diagnostics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Accelerate Diagnostics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Accelerate Diagnostics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Accelerate Diagnostics Estimiated After-Hype Price Volatility

In the context of predicting Accelerate Diagnostics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Accelerate Diagnostics' historical news coverage. Accelerate Diagnostics' after-hype downside and upside margins for the prediction period are 0.00 and 23.04, respectively. We have considered Accelerate Diagnostics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.04
0.04
After-hype Price
23.04
Upside
Accelerate Diagnostics is out of control at this time. Analysis and calculation of next after-hype price of Accelerate Diagnostics is based on 3 months time horizon.

Accelerate Diagnostics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Accelerate Diagnostics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Accelerate Diagnostics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Accelerate Diagnostics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  9.36 
23.00
  0.19 
  1.62 
8 Events / Month
4 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.04
0.04
9.65 
115,000  
Notes

Accelerate Diagnostics Hype Timeline

Accelerate Diagnostics is presently traded for 0.04. The entity has historical hype elasticity of -0.19, and average elasticity to hype of competition of 1.62. Accelerate is forecasted to decline in value after the next headline, with the price expected to drop to 0.0361. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -9.65%, whereas the daily expected return is presently at -9.36%. The volatility of related hype on Accelerate Diagnostics is about 13299.32%, with the expected price after the next announcement by competition of 1.66. About 38.0% of the company shares are held by company insiders. The company recorded a loss per share of 2.15. Accelerate Diagnostics had not issued any dividends in recent years. The entity had 1:10 split on the 12th of July 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Accelerate Diagnostics Related Hype Analysis

Having access to credible news sources related to Accelerate Diagnostics' direct competition is more important than ever and may enhance your ability to predict Accelerate Diagnostics' future price movements. Getting to know how Accelerate Diagnostics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Accelerate Diagnostics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CVRXCVRx Inc 0.00 0 per month 7.38  0.09  11.74 (5.03) 50.43 
NPCENeuropace(0.02)2 per month 0.00 (0.03) 5.22 (5.92) 48.86 
ANIKAnika Therapeutics 0.00 0 per month 0.00 (0.13) 4.73 (4.60) 23.94 
AXGNAxogen Inc 0.00 0 per month 0.00 (0.12) 3.93 (4.67) 27.13 
AORTArtivion 0.00 0 per month 1.03  0.13  3.50 (2.03) 18.73 
SGHTSight Sciences 0.00 0 per month 4.60  0.04  6.90 (4.92) 24.84 
OFIXOrthofix Medical 0.00 0 per month 0.00 (0.18) 3.87 (3.75) 14.80 
AVNSAvanos Medical 0.00 0 per month 0.00 (0.11) 3.98 (3.90) 9.98 
CNMDCONMED 2.12 12 per month 2.20 (0.04) 3.82 (4.06) 20.87 
KIDSOrthopediatrics Corp 0.00 0 per month 2.22 (0.02) 4.06 (3.51) 11.10 
SRDXSurModics 0.00 0 per month 1.98  0  3.12 (1.95) 15.01 
ITGRInteger Holdings Corp 0.05 11 per month 0.00 (0.13) 2.14 (2.13) 10.63 
OSAProSomnus, Common Stock 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
LIVNLivaNova PLC 0.00 0 per month 1.58  0.05  2.66 (2.79) 28.73 
ELMDElectromed 0.60 10 per month 0.00 (0.14) 3.34 (5.49) 17.42 
LUNGPulmonx Corp 0.00 0 per month 0.00 (0.12) 7.78 (8.35) 26.78 
IRMDIradimed Co 0.19 13 per month 1.56  0  3.24 (2.45) 17.04 

Accelerate Diagnostics Additional Predictive Modules

Most predictive techniques to examine Accelerate price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Accelerate using various technical indicators. When you analyze Accelerate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Accelerate Diagnostics Predictive Indicators

The successful prediction of Accelerate Diagnostics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Accelerate Diagnostics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Accelerate Diagnostics based on analysis of Accelerate Diagnostics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Accelerate Diagnostics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Accelerate Diagnostics's related companies.

Story Coverage note for Accelerate Diagnostics

The number of cover stories for Accelerate Diagnostics depends on current market conditions and Accelerate Diagnostics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Accelerate Diagnostics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Accelerate Diagnostics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Accelerate Diagnostics Short Properties

Accelerate Diagnostics' future price predictability will typically decrease when Accelerate Diagnostics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Accelerate Diagnostics often depends not only on the future outlook of the potential Accelerate Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Accelerate Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding23.3 M
Cash And Short Term Investments16.3 M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Consideration for investing in Accelerate Stock

If you are still planning to invest in Accelerate Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Accelerate Diagnostics' history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation